Cns Pharmaceuticals Inc (CNSP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 11,075 | 14,040 | 1,307 | 2,626 | 5,380 |
| Receivables | 133 | N/A | N/A | N/A | N/A |
| TOTAL | $12,786 | $15,496 | $2,516 | $3,955 | $6,189 |
| Non-Current Assets | |||||
| PPE Net | 24 | 23 | 28 | 31 | 23 |
| Other Non-Current Assets | 334 | 334 | 441 | 0 | 0 |
| TOTAL | $358 | $358 | $469 | $31 | $23 |
| Total Assets | $13,145 | $15,853 | $2,985 | $3,986 | $6,211 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,058 | 946 | 250 | 151 | 191 |
| Accrued Expenses | 535 | 520 | 261 | 111 | 145 |
| TOTAL | $1,902 | $1,905 | $511 | $261 | $336 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $1,902 | $1,905 | $511 | $261 | $336 |
| Shareholders' Equity | |||||
| Common Shares | 25 | 24 | 17 | 17 | 17 |
| Retained earnings | -24,560 | -20,946 | -17,941 | -15,930 | -13,457 |
| TOTAL | $11,243 | $13,948 | $2,475 | $3,725 | $5,875 |
| Total Liabilities And Equity | $13,145 | $15,853 | $2,985 | $3,986 | $6,211 |